1. 1831PDMolecular differences between colorectal cancers with mutations in histone modifiers genes vs wild-type (WT) tumors. (23rd October 2018) Authors: Puccini, A; Poorman, K; Goldberg, R; Shields, A F; Winerip, M; Korn, W M; Berger, M D; Tokunaga, R; Naseem, M; Battaglin, F; Zhang, W; Soni, S; Hwang, J J; Philip, P; Marshall, J L; Lenz, H-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 422PFirst-in-human study of the monopolar spindle 1 (Mps1) kinase inhibitor BAY 1161909 in combination with paclitaxel in subjects with advanced malignancies. (23rd October 2018) Authors: Lorusso, P; Chawla, S P; Bendell, J; Shields, A F; Shapiro, G; Rajagopalan, P; Cyris, C; Bruns, I; Mei, J; Souza, F; Rasco, D; Eder, J P; Tolcher, A W Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?. (9th February 2018) Authors: Sobrero, A; Grothey, A; Iveson, T; Labianca, R; Yoshino, T; Taieb, J; Maughan, T; Buyse, M; André, T; Meyerhardt, J; Shields, A F; Souglakos, I; Douillard, J -Y; Cervantes, A Journal: Annals of oncology Issue: Volume 29:Number 5(2018) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗